1. Home
  2. MVBF vs CUVL Comparison

MVBF vs CUVL Comparison

Compare MVBF & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

N/A

Current Price

$23.01

Market Cap

335.2M

Sector

Finance

ML Signal

N/A

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$4.92

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
MVBF
CUVL
Founded
1997
1999
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Banks
Miscellaneous
Sector
Finance
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
335.2M
374.2M
IPO Year
2004
2004

Fundamental Metrics

Financial Performance
Metric
MVBF
CUVL
Price
$23.01
$4.92
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $30.50
N/A
AVG Volume (30 Days)
★ 65.8K
5.6K
Earning Date
10-29-2026
08-27-2026
Dividend Yield
★ 2.91%
0.60%
EPS Growth
N/A
N/A
EPS
★ 1.35
N/A
Revenue
★ $3,400,000.00
N/A
Revenue This Year
N/A
$0.47
Revenue Next Year
$10.88
$6.25
P/E Ratio
$17.30
★ N/A
Revenue Growth
★ 51.92
N/A
52 Week Low
$23.01
$4.79
52 Week High
$31.99
$8.20

Technical Indicators

Market Signals
Indicator
MVBF
CUVL
Relative Strength Index (RSI) 21.24 30.91
Support Level N/A N/A
Resistance Level $26.60 $5.34
Average True Range (ATR) 0.88 0.16
MACD -0.20 -0.01
Stochastic Oscillator 3.26 16.67

Price Performance

Historical Comparison
MVBF
CUVL

About MVBF MVB Financial Corp.

MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: